<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240123060780N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-19</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Effect of sound frequencies on pain level</public_title>
      <acronym></acronym>
      <scientific_title>Investigating effects of sound frequencies on pain, comfort and anxiety levels in venous-arterial blood sampling, intramuscular injection, and venous intra-vascular access process</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>300</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75565</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization of the samples in this study is done by computer software. By the software, a random sequence of letters A, B, C, D, E, F, G, H, I, G is assigned to the intervention and control groups. . In the output of the software, blocks are created with a sequence of 8 and 10 random letters (each letter is considered for a group). Then these obtained blocks are placed in sealed envelopes. Before starting the study, one of the researchers opens one of the envelopes and finally, according to the sequence of letters, the patient is placed in one of the intervention or control groups, Blinding description: In control group 1; Headphones are placed on the patient's ear. But the headphones have no function, and the patient is able to hear the surrounding sounds naturally through the holes made on the ear part of the headphones. In control group 2; Healthy headphones but without sound function are placed on the patient's ear so that he cannot hear the surrounding sounds. In the intervention groups; Healthy headphones with sound function with a specific frequency are used. Due to the identical appearance of the interventions and the patient's lack of information about the grouping and type of stimulation intervention frequency, the patients were blinded to the intervention. Blood sampling and intramuscular injections are done by the co-colleague. Audio frequency was applied through headphones and audio frequency settings were done through Bluetooth headphones. The other colleague who registers the variables does not know how to group and the type of frequency received by the patients.</study_design>
      <phase>3</phase>
      <hc_freetext>Pain.</hc_freetext>
      <i_freetext>Intervention 1: Control group: during each of the procedures, the patients do not receive any stimulation or analgesia, and the procedure is performed according to the routine of the department and the noise level of the environment. Intervention 2: Control group: during each of the procedures, passive wireless headphones are placed on both ears of the patients so that the intensity of the ambient sound is less than 5 dB, and the patients in this group do not receive any sound stimuli. Intervention 3: Intervention group: 5 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 5 Hz is performed from one minute before the procedure until its completion. Intervention 4: Intervention group: 10 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 10 Hz is performed from one minute before the procedure until its completion. Intervention 5: Intervention group: 15 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 15 Hz is performed from one minute before the procedure until its completion. Intervention 6: Intervention group: 20 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 20 Hz is performed from one minute before the procedure until its completion. Intervention 7: Intervention group: 30 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 30 Hz is performed from one minute before the procedure until its completion. Intervention 8: Intervention group: 40 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 40 Hz is performed from one minute before the procedure until its completion. Intervention 9: Intervention group: 50 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 50 Hz is performed from one minute before the procedure until its completion. Intervention 10: Intervention group: 100 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 100 Hz is performed from one minute before the procedure until its completion.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No decision has been made yet.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Said mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Medicine, St. University, shahid Shiroudi Boulevard, Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714869914</zip>
        <telephone>+98 83 3427 4618</telephone>
        <email>dr.saidmohamadi@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Said mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Medicine, St. University, shahid Shiroudi Boulevard, Kermanshah</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714869914</zip>
        <telephone>+98 83 3427 4618</telephone>
        <email>dr.saidmohamadi@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Full consciousness
Literacy, reading, writing
Verbal ability and healthy vision
The skin of the study area should be healthy
No peripheral edema in the intervention area



.</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Addiction
Taking sedatives and anesthetic during the last 24 hours
Having a pacemaker and implantable cardiac device and defibrillators
History of diabetes
Patient restlessness</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute pain, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
      <i_code>Placebo</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: during each of the procedures, the patients do not receive any stimulation or analgesia, and the procedure is performed according to the routine of the department and the noise level of the environment.</i_keyword>
      <i_keyword>Control group: during each of the procedures, passive wireless headphones are placed on both ears of the patients so that the intensity of the ambient sound is less than 5 dB, and the patients in this group do not receive any sound stimuli.</i_keyword>
      <i_keyword>Intervention group: 5 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 5 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 10 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 10 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 15 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 15 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 20 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 20 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 30 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 30 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 40 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 40 Hz is performed from one minute before the procedure until its completion</i_keyword>
      <i_keyword>Intervention group: 50 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 50 Hz is performed from one minute before the procedure until its completion.</i_keyword>
      <i_keyword>Intervention group: 100 Hz sound stimulation group: wireless headphones are placed on both ears one minute before each procedure. Sound stimulation with a frequency of 100 Hz is performed from one minute before the procedure until its completion.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: The  pain level is measured immediately after the procedure and also in 1, 3 and 5 minutes after the procedure is completed. Method of measurement: The visual analog scale.</prim_outcome>
      <prim_outcome>Comfort level. Timepoint: It is measured in 5 minutes after each procedure (injection or blood sampling). Method of measurement: The visual analog scale.</prim_outcome>
      <prim_outcome>Stress level. Timepoint: 5 minutes after each procedure. Method of measurement: The visual analog scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart rate. Timepoint: The  hear rate is measured before and after procedure (injection and blood sampling) and also in 1, 3 and 5 minutes after the procedure is completed. Method of measurement: Using portable pulse oximetry.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-01-30</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>No. 2 Central Building, Kermanshah University of Medical Sciences, Shahid Beheshti Street, Kermanshah, Iran Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
